First Command Advisory Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.47K Hold
5
﹤0.01% 1064
2026
Q1
$1.39K Hold
5
﹤0.01% 983
2025
Q4
$1.51K Buy
+5
New +$1.56K ﹤0.01% 689

Other funds holding BIO

First Command Advisory Services's BIO Position: Q2 2026 in Review

First Command Advisory Services held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 5 shares worth $1.47K. The position accounts for ﹤0.01% of the portfolio, ranked #1064.

First Command Advisory Services first reported a position in BIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.51K in Q4 2025. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • First Command Advisory Services held 5 shares of Bio-Rad Laboratories Class A worth $1.47K as of Q2 2026.
  • First Command Advisory Services left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of First Command Advisory Services's portfolio in Q2 2026, its #1064 holding.
  • First Command Advisory Services first reported a position in Bio-Rad Laboratories Class A in Q4 2025 and has held it in 3 quarters since.
  • First Command Advisory Services's Bio-Rad Laboratories Class A position peaked at $1.51K in Q4 2025.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.